Neil Desai
@ndesai2005
Followers
1K
Following
7K
Statuses
1K
Radiation oncologist in GU malignancies, father and low skill/high enthusiasm DIY’er. Views are my own. @UTSW
Dallas, TX
Joined September 2015
@DrRanaMcKay @UCSDCancer @PCFnews Great event and patient & caregiver perspective in focus - thanks for having me to observe! @AdityaBagrodia
1
0
2
RT @DrRanaMcKay: Getting ready to kick off the third annual Prostate Cancer Patient Summit hosted by @UCSDCancer and @PCFnews. A great…
0
8
0
RT @urotoday: Enfortumab vedotin and stereotactic radiation tested before surgery in #MIBC in the STAR-EV trial. @TiansterZhang @UTSWMedCen…
0
7
0
RT @drjefstathiou: Great to see so many friends and colleagues committed to innovative and practice-changing clinical trials at @NRGonc in…
0
14
0
@UTSW_RadOnc @BinCaiMedPhys Thank you to study sponsor @reflexionmed and to support of @TelixPharma for this developmental study’s use of Illuccix. Early but important technical work towards using PSMA as a fiducial for treatment, response based targeting and more. Look forward to enrolling and reporting
0
0
7
RT @UroDocAsh: Hats off to Fernando Maluf for launching a groundbreaking RCT comparing XRT and RC in bladder cancer. This trial promises to…
0
25
0
RT @TylerSbrt: Please consider signing up. It will only take you a few minutes to contour 1 prostate, and you will be able to compare your…
0
3
0
@NiuSanford @aleberlin2 PI and im his PowerPoint assistant - along with strong study team- “secret” is jumping on the train of amazing NRG GU prostate Ca trial machine led by @felixfengmd @DrPaulNguyen @DrSpratticus @whallradonc and group of engaged investigators
1
1
13
0
0
4
RT @ASTRO_org: ASTRO is pleased to announce the ACS-ASTRO Felix Feng, MD Clinician Scientist Development Grant Award, honoring the career &…
0
29
0
RT @MLSTjournal: Great new work by Dan Nguyen @ChenyangShenPhD @SteveJiangPhD et al @MAIA_Laboratory @UTSW_ROPhysRes @UTSW_RadOnc - 'Qualit…
0
7
0
RT @NiuSanford: Excited to share about NRG GI-011 (aka LAP100) – anticipated opening in mid/early 2025. In this Phase III RCT, we are asse…
0
57
0
RT @DrAndrewLoblaw: @aleberlin2 presenting how AI is/will improve workflow for #Radiotherapy. We just need to decide which part of the ch…
0
2
0
RT @DrChoueiri: JUST IN: SunRISe-2 study with Intravesical TAR200+Cetrelimab (PD1 inh) vs. Chemoradiation in patients with muscle-invasive…
0
39
0
RT @AmarUKishan: RAIDER trial out in @EUplatinum Congrats to @robert_huddart @EmmaHall71 @achoud72 on this large…
0
41
0
@NicholasZaorsky @freddyeescorcia @Soum_Roy_RadOnc @UHhospitals @RadOncUH @CWRUSOM @cwru @CaseUrology Wonderful recruitment - amazing GU team you have there. Great to see you both again
1
0
9
RT @urotoday: F-SHARP: Initial results of a multi-institutional phase 1/2 trial of focal dose-escalated salvage HDR brachytherapy for radio…
0
4
0
@mskcc bladder group represented well at ASTRO with first @IyerGopa and now @h_alahmadie presenting on small cell disease management. Important lessons for us to recognize molecular underpinnings as targeted systemic ADCs enter bladder pres space
0
0
1
@achoud72 @swinton_martin @MCRCnews @UoM_DCS @RT_physics Very interesting - I’m listening to @RTendulkarMD ‘s always insightful discussion at scientific highlights session next door and will surely come pick Dr Swinton’s mind. Great to see the hypoxia story evolve with our advancing imaging platforms with RT
0
0
5
@YashSoni01 @UTSW_RadOnc did a great job presenting on behalf of our collaboration with @l_ballas @CedarsSinai and Dr Derrick Lock at USC on safety of EV with RT which lays foundation for ongoing studies such as @TiansterZhang ‘s STAR-EV
0
0
4